Jun Murata

1.9k total citations
56 papers, 1.7k citations indexed

About

Jun Murata is a scholar working on Molecular Biology, Immunology and Allergy and Oncology. According to data from OpenAlex, Jun Murata has authored 56 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 23 papers in Immunology and Allergy and 20 papers in Oncology. Recurrent topics in Jun Murata's work include Cell Adhesion Molecules Research (23 papers), Peptidase Inhibition and Analysis (16 papers) and Glycosylation and Glycoproteins Research (14 papers). Jun Murata is often cited by papers focused on Cell Adhesion Molecules Research (23 papers), Peptidase Inhibition and Analysis (16 papers) and Glycosylation and Glycoproteins Research (14 papers). Jun Murata collaborates with scholars based in Japan, United Kingdom and United States. Jun Murata's co-authors include Ikuo Saiki, Koji Murakami, Ichiro Azuma, Hideo Hasegawa, Chisato Wakabayashi, Hideki Fujii, Masaru Ogasawara, Seiichi Tokura, Hideki Fujii and Yasushi Kuraishi and has published in prestigious journals such as Advanced Drug Delivery Reviews, Biochemical and Biophysical Research Communications and International Journal of Cancer.

In The Last Decade

Jun Murata

56 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jun Murata Japan 23 798 340 273 239 233 56 1.7k
Maria Grazia Cattaneo Italy 26 827 1.0× 261 0.8× 88 0.3× 191 0.8× 96 0.4× 72 1.9k
Roland Lang Austria 27 733 0.9× 254 0.7× 754 2.8× 526 2.2× 55 0.2× 73 2.3k
Florence Miller France 19 570 0.7× 398 1.2× 46 0.2× 169 0.7× 64 0.3× 26 1.8k
Heidi C. Horner United States 14 374 0.5× 277 0.8× 109 0.4× 146 0.6× 44 0.2× 21 1.3k
Tsui‐Ting Ching United States 18 822 1.0× 139 0.4× 82 0.3× 53 0.2× 100 0.4× 30 1.7k
Scott Greenfeder United States 16 811 1.0× 111 0.3× 159 0.6× 127 0.5× 47 0.2× 26 1.9k
Tomo‐o Ishikawa United States 24 1.1k 1.3× 395 1.2× 24 0.1× 169 0.7× 145 0.6× 43 2.3k
Yong‐Sung Juhnn South Korea 25 967 1.2× 311 0.9× 26 0.1× 207 0.9× 65 0.3× 68 1.6k
Taehoon G. Lee South Korea 20 1.0k 1.3× 136 0.4× 36 0.1× 381 1.6× 51 0.2× 25 1.7k
Won‐Sik Shim South Korea 21 1.2k 1.5× 149 0.4× 214 0.8× 434 1.8× 18 0.1× 69 2.8k

Countries citing papers authored by Jun Murata

Since Specialization
Citations

This map shows the geographic impact of Jun Murata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Murata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Murata more than expected).

Fields of papers citing papers by Jun Murata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun Murata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Murata. The network helps show where Jun Murata may publish in the future.

Co-authorship network of co-authors of Jun Murata

This figure shows the co-authorship network connecting the top 25 collaborators of Jun Murata. A scholar is included among the top collaborators of Jun Murata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jun Murata. Jun Murata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Iwashita, Jun, et al.. (2022). Type IV collagen reduces MUC5AC secretion in the lungs of ovalbumin-sensitized mice. Frontiers in Pharmacology. 13. 851374–851374. 4 indexed citations
2.
Watanabe, Masafumi, Koichi Saito, Sho Sato, et al.. (2012). Effect of ectopic expression of homeoprotein EGAM1C on the cell morphology, growth, and differentiation in a mouse embryonic stem cell line, MG1.19 cells. Reproduction. 143(4). 477–489. 15 indexed citations
3.
Iwashita, Jun, et al.. (2011). Inhibition of E-Cadherin Dependent Cell-Cell Contact Promotes MUC5AC Mucin Production through the Activation of Epidermal Growth Factor Receptors. Bioscience Biotechnology and Biochemistry. 75(4). 688–693. 8 indexed citations
4.
Nagakawa, Osamu, Jun Murata, Akira Junicho, et al.. (2002). Vasoactive intestinal peptide (VIP) enhances the cell motility of androgen receptor-transfected DU-145 prostate cancer cells (DU-145/AR). Cancer Letters. 176(1). 93–99. 6 indexed citations
5.
Nagakawa, Osamu, Koji Murakami, Masaru Ogasawara, et al.. (1999). Effect of chromogranin A (pancreastatin) fragment on invasion of prostate cancer cells. Cancer Letters. 147(1-2). 207–213. 8 indexed citations
6.
Sakamoto, Takashi, Hideki Fujii, Jun Murata, et al.. (1997). Characterization of a Liver Metastatic Variant of Murine Colon 26 Carcinoma Cells. Tumor Biology. 18(2). 113–122. 56 indexed citations
7.
Ogasawara, Masaru, et al.. (1997). Differential effect of intestinal neuropeptides on invasion and migration of colon carcinoma cells in vitro. Cancer Letters. 119(1). 125–130. 31 indexed citations
8.
Fujii, Hideki, Takaaki Mishima, Jun Murata, et al.. (1996). Inhibitory Effect of a Traditional Chinese Medicine, Juzen‐taiho‐to, on Progressive Growth of Weakly Malignant Clone Cells Derived from Murine Fibrosarcoma. Japanese Journal of Cancer Research. 87(10). 1039–1044. 24 indexed citations
9.
Fujii, Hideki, Hideto Mori, Masayoshi Kojima, et al.. (1995). Antimetastatic Activities of Synthetic Arg-Gly-Asp-Ser (RGDS) and Arg-Leu-Asp-Ser (RLDS) Peptide Analogues and Their Inhibitory Mechanisms.. Biological and Pharmaceutical Bulletin. 18(12). 1681–1688. 18 indexed citations
10.
Kobayashi, Takahiko, Koichi Honke, Yasuhiro Kuramitsu, et al.. (1994). Cell‐surface sulfoglycolipids are involved in the attachment of renal‐cancer cells to laminin. International Journal of Cancer. 56(2). 281–285. 23 indexed citations
11.
Murata, Jun, et al.. (1992). Differences in Chemotaxis to Fibronectin in Weakly and Highly Metastatic Tumor Cells. Japanese Journal of Cancer Research. 83(12). 1327–1333. 17 indexed citations
12.
Saiki, Ikuo, Yoshihiro Matsumoto, Jun Murata, et al.. (1991). Recombinant Fusion Polypeptide with Cell‐ and Heparin‐binding Domains of Fibronectin Inhibits Liver Metastasis of L5178Y‐ML25 Lymphoma Cells. Japanese Journal of Cancer Research. 82(10). 1120–1129. 18 indexed citations
13.
Murata, Jun, Ikuo Saiki, Ryu Ogawa, et al.. (1991). Molecular properties of poly(RGD) and its binding capacities to metastatic melanoma cells. International journal of peptide & protein research. 38(3). 212–217. 17 indexed citations
14.
Saiki, Ikuo, Jun Murata, Kazuhiko Matsuno, et al.. (1990). Anti‐metastatic and Anti‐invasive Effects of Polymeric Arg‐Gly‐Asp (RGD) Peptide, Poly(RGD), and Its Analogues. Japanese Journal of Cancer Research. 81(6-7). 660–667. 38 indexed citations
15.
Murata, Jun, Ikuo Saiki, Kazuhiko Matsuno, Seiichi Tokura, & Ichiro Azuma. (1990). Inhibition of Tumor Cell Arrest in Lungs by Antimetastatic Chitin Heparinoid. Japanese Journal of Cancer Research. 81(5). 506–513. 24 indexed citations
16.
Saiki, Ikuo, Jun Murata, Yoshihiro Matsumoto, et al.. (1990). Inhibition of Lung Metastasis by Synthetic and Recombinant Fragments of Human Fibronectin with Functional Domains. Japanese Journal of Cancer Research. 81(10). 1003–1011. 36 indexed citations
17.
Saiki, Ikuo, et al.. (1989). Inhibition of Tumor Cell Invasion by Ubenimex (Bestatin) in vitro. Japanese Journal of Cancer Research. 80(9). 873–878. 78 indexed citations
18.
Murata, Jun, et al.. (1989). Inhibition of tumour cell adhesion by anti-metastatic polypeptide containing a repetitive Arg-Gly-Asp sequence. International Journal of Biological Macromolecules. 11(4). 226–232. 7 indexed citations
19.
Saiki, Ikuo, Hiroaki Maeda, Jun Murata, et al.. (1989). Antimetastatic effect of endogenous tumor necrosis factor induced by the treatment of recombinant interferon γ followed by an analogue (GLA-60) to synthetic lipid A subunit. Cancer Immunology Immunotherapy. 30(3). 151–157. 17 indexed citations
20.
Murata, Jun, et al.. (1989). Inhibitory Effect of Chitin Heparinoids on the Lung Metastasis of B16‐BL6 Melanoma. Japanese Journal of Cancer Research. 80(9). 866–872. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria Grazia Cattaneo Breakdown of academic impact, for papers by Roland Lang Breakdown of academic impact, for papers by Florence Miller Breakdown of academic impact, for papers by Heidi C. Horner Breakdown of academic impact, for papers by Tsui‐Ting Ching Breakdown of academic impact, for papers by Scott Greenfeder Breakdown of academic impact, for papers by Tomo‐o Ishikawa Breakdown of academic impact, for papers by Yong‐Sung Juhnn Breakdown of academic impact, for papers by Taehoon G. Lee Breakdown of academic impact, for papers by Won‐Sik Shim
Rankless by CCL
2026